# Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors

> **NCT04675320** · — · UNKNOWN · sponsor: **Centre Georges Francois Leclerc** · enrollment: 50 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** blood samples

## Key facts

- **NCT ID:** NCT04675320
- **Lead sponsor:** Centre Georges Francois Leclerc
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-07
- **Primary completion:** 2022-11-10
- **Final completion:** 2024-11-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04675320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04675320, "Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04675320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*